Novo says Wegovy pill outperforms Lilly's oral GLP-1
Wegovy semaglutide tablets. Michael Siluk | Universal Image Group | fake images The Wegovy pill showed more pronounced weight loss…
Social issues
Eli Lilly GLP-1 Foundayo pill approved for obesity
The US Food and Drug Administration has approved Eli LillyThe GLP-1 pill, the company said, is a major milestone for…
Iran war wipes out $100 billion of luxury stocks
A version of this article first appeared in CNBC's Inside Wealth newsletter with Robert Frank, a weekly guide for high-net-worth…
ACA Enrollees Left Uninsured After Enhanced Subsidies Expire: KFF Survey
Many Americans are feeling the financial pain following the expiration of enhanced federal subsidies for health insurance from the Affordable…
J&J's Icotyde Psoriasis Pill Rivals Tremfya Skyrizi IL-23 Injections
Signs outside the Johnson & Johnson offices in Irvine, California, U.S., on Friday, October 10, 2025. Kyle Grillot Bloomberg |…
Stopping GLP-1 increases cardiovascular risks: study
In a pharmacy you see boxes of Ozempic and Wegovy manufactured by Novo Nordisk. Hollie Adams | Reuters A version…
FDA approves leucovorin for brain folate deficiency, but not autism
The Food and Drug Administration on Tuesday approved a decades-old prescription vitamin called leucovorin as the first treatment for a…
FDA Vaccine Director to Resign in April After Series of Controversial Decisions
The Food and Drug Administration logo before a news conference at Health and Human Services Headquarters in Washington, April 22,…
Eli Lilly Launches Program to Increase Employer Coverage of Obesity Drugs
Eli Lilly On Thursday it launched a new program designed to help more employers cover obesity medications in the U.S.,…
What's next for Novo Nordisk's anti-obesity drug CagriSema?
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…